RJ Biotech Ltd. said its normalized net income for the fiscal second quarter ended Sept. 30 was 2.10 Indian rupees per share, an increase from 6 paise per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 19.9 million rupees, a gain from 560,630 rupees in the year-earlier period.
The normalized profit margin rose to 17.8% from 1.2% in the year-earlier period.
Total revenue climbed year over year to 111.9 million rupees from 47.6 million rupees, and total operating expenses increased 89.1% from the prior-year period to 71.5 million rupees from 37.8 million rupees.
Reported net income rose year over year to 31.8 million rupees, or 3.36 rupees per share, from 897,000 rupees, or 9 paise per share.
As of Nov. 2, US$1 was equivalent to 65.58 Indian rupees.